chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Nausea-Mild
He came to the pharmacy today to report that he is having an allergic reaction to his first dose of Moderna Vaccine that he received on 8/2/2021. Patient was not sure of the exact date of onset but he estimated it was a couple days after he received the shot. He has been using A&D ointment and the rash is localized on his left hand. I recommended he use Benadryl instead and to seek medical help if reaction worsens and explained other signs of allergic reactions to look out for.
Received first of two SHINGRIX injections on 5/26. The next day experienced a significant stiff neck on the side of the injection site. Each day since, the pain has increased to the point where I cannot lie down or sit upright without NAPROSYN.
We had a patient who got Covid-19 vaccine on 03/23/2021 at 11:32 and was feeling dizzy and lightheaded.  Patient reported to pharmacist while he was sitting on chair. So, I advise him to lay down on the floor with elevated feet. I also provide cold compress to the patient. I checked his blood pressure, and it was within normal range (124/76, 126/78) with the pulse rate was 60. Patient reported that he did not eat anything since morning, so he thinks his lightheadedness is due to low blood sugar. I gave him water after he set down back on the chair to make sure that he is hydrated well enough. We observed him for total of 45 minutes to make sure he was feeling fine before he left the pharmacy area. Patient called family member to pick him up.
Patient had mild tingling and swollen lips after first dose.  Took Benadryl at home. After second dose (aprox. 10 minutes after shot) patient again experienced tingling and swelling of lips. Patient offered PRN benadryl at site. Refused and said she would monitor at home after additional wait of 15 minutes. Waited 45 minutes total.
Pt could not recall hx measles, chicken pox when being vaccinated to travel - received MMR, varicella, typhoid, HepA 8/12/14 - developed rib cage pain following day - diagnosed with shingles Monday 8-18-14.
Severe joint pain, especially in hips, knees and hands lasting approximately 72 hours after first onset of symptoms. Treatment Tylenol/NSAIDs. Resolved on its own.
Patient received second dose of Moderna vaccine and a few minutes later stated she "can't swallow" and her throat felt tight. Patient received benadryl 25 mg IM  and was able to swallow. A second medical first response was called shortly after for continued difficulty swallowing, and the patient was given epinephrine IM.  The patient was then transferred to the ED, where she received dexamethasone 10 mg IV and a liter bolus of NS.   Patient was discharged from the ED at 11 am.
Migraine after 2nd vaccine that got progressively worse each day; Orthostatic hypotension; Mild fever; Tachycardia when standing; This is a spontaneous report from a contactable pharmacist, the patient. A 41-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Aug2021 at 15:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included bipolar II disorder, cerebrospinal fluid (CSF) leak, Hashimotos, Ehlers-Danlos syndrome (EDS) and sulfa allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lurasidone hydrochloride (LATUDA), levothyroxine (MANUFACTURER UNKNOWN), dexamfetamine sulfate/ amfetamine sulfate/ dexamfetamine saccharate/ amfetamine aspartate monohydrate (MYDAYIS), and fremanezumab (AJOVY); all for unknown indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Aug2021 at 15:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On 28Aug2021 at 20:30, the patient experienced migraine after second vaccine that got progressively worse each day, orthostatic hypotension, mild fever and tachycardia when standing. Since the vaccination, the patient had been tested for COVID-19. On 20Aug2021 and 24Aug2021, the patient underwent COVID test via nasal swab and the result were negative. Therapeutic measures were taken as a result of the events which included treatment with zolmitriptan (ZOMIG) and paracetamol (TYLENOL). The clinical outcome of the events migraine after second vaccine that got progressively worse each day, orthostatic hypotension, mild fever and tachycardia when standing were not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Did not feel well after shot; This is a spontaneous report received from a non-contactable reporter (Consumer).  A female patient of unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On an unknown date after shot, the patient did not feel well. The clinical outcome of the event did not feel well was unknown at the time of this report.   Amendment: This follow-up report is being submitted to amend previously reported information: Country for patient and Vaccination Facility Country added.
Temperature 104 - 105 degrees and crying for 5-6 hours after injections.
Covid19 Bivalent vaccine lot # GP4345 had a 10 week expiry of 04/07/2023 administered past the BUD on 04/0/2023. We contact Pfizer on 04/18/2023 for Stability Assessment: Stability data DOES SUPPORT
Started coughing/Felt like an upper respiratory cough/Cough is like a tickle; Woken up out of sleep by the cough; Notice tiny amount of green sputum; This spontaneous case was reported by a nurse and describes the occurrence of COUGH (Started coughing/Felt like an upper respiratory cough/Cough is like a tickle), POOR QUALITY SLEEP (Woken up out of sleep by the cough) and SPUTUM DISCOLOURED (Notice tiny amount of green sputum) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022B21A and 045821A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMIN C [ASCORBIC ACID] and ZINC for an unknown indication.   On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Jun-2021, the patient experienced COUGH (Started coughing/Felt like an upper respiratory cough/Cough is like a tickle), POOR QUALITY SLEEP (Woken up out of sleep by the cough) and SPUTUM DISCOLOURED (Notice tiny amount of green sputum). The patient was treated with PSEUDOEPHEDRINE HYDROCHLORIDE (SUDAFED [PSEUDOEPHEDRINE HYDROCHLORIDE]) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, COUGH (Started coughing/Felt like an upper respiratory cough/Cough is like a tickle), POOR QUALITY SLEEP (Woken up out of sleep by the cough) and SPUTUM DISCOLOURED (Notice tiny amount of green sputum) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA 1273 in response to event was not applicable.  The patient's cough was like a tickle. It comes and goes. She was often woken up out of her sleep by the cough. Patient noticed a tiny amount of green sputum and also stated that she was able to do normal activities such as paddle boarding.  No treatment information was reported.
fever; This is a spontaneous report from a non-contactable physician, the patient. A male patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on an unspecified date for COVID-19 immunization. On an unspecified date, the patient experienced fever for 24 hours. The clinical outcome of fever was resolved on an unspecified date.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Vomiting, fussiness and decreased oral intake for 12-18 hrs after vaccines were given.
Post vax, the pt developed myalgias, fever, rash which was maculopapular, centrally and peripherally, and diarrhea.
On May 24, 2021 at 4:38 my husband made like a death cry then started convulsing. As he was convulsing dark red blood was coming out his mouth. He was dark blue and not breathing. He finally stared breathing again around 6 minutes later. Then he started at the ceiling. He was not responding or blinking. That is when he started breathing like his chest was restricted and he was snoring-eyes wide open. When he finally came to his speech was slurred and he was very confused. He didn't have any recollection of what happened. He asked me why I was crying with blood down his face and down his shirt.  The ambulance took him to Hospital. They are a trauma center. Then July 22, at 11:10 at night while I was sleeping I woke up to him gurgling. He was sitting up with his legs over the side of the bed. He wasn't facing me but I could see the outline of him from the nigh lights. I rushed around the bed and he was convulsing. When he came to he was slurring his words-they were random words
pt recvd vax;next year in apr94 pt was dx w/ amyotrophic lateral sclerosis;
Information has been received from a medical assistant concerning an 8 week old patient who on 11-NOV-2010 was vaccinated with a dose of VARIVAX (Merck) (Lot# unknown) and a dose of MMR II (Lot# unknown). No adverse effect was reported. Follow up information has been received from the medical assistant concerning the 8 week old male patient with no illness at time of vaccination and no pre-existing allergies, birth defects or medical conditions who on 04-NOV-2010 at 10:30 (previously reported as 11-NOV-2010) was vaccinated subcutaneously with a first dose of VARIVAX (Merck) (Lot# 668255/0904Z) and a first dose of MMR II (Lot# 664455/0588Z). The medical assistant reported that wrong vaccines were given to baby. Patient did well with no fever and no adverse reaction. The patient did not seek medical attention. No further information is available.
Triggered an Auto immune flair up response I get with Sjogrens syndrome..Generalize muscle and joint pain,  Extremely dry eyes, mouth.  Fatigue.  Dizziness.  Diarrhea. from 1/29/2021 to 1/31/3021
Had COVID 17 Dec 2020    Recovered Had vaccination shot 6 Oct 2021 By 1am on the 7 Oct had severe symptoms - chills, muscle aches, headache, sweats, fatigue, tiredness and inability to sleep.   Way more severe than when I had COVID  Started taking Advil by end of day on the 8th. Most severe symptoms subsided by the end of day on the 11th. Sweats and chills continued until the 16th.   Persistent headache, fatigue and tiredness since the shot. Headache pronounced from early morning until waking up from afternoon nap. Fatigue and tiredness very severe to the point that I can't work or function after 3-4pm every day.   Since the  18th I have been a zombie on the couch from 3 to 4or5 pm  for several days trying to fight to stay awake. By the 10th finally giving up and taking a nap from 4 to 6or7pm every day. Tired to the point that I can't even leave the house and would not think of driving in the late afternoon.  Fatigue since the shot has left me unable to exercise more than a hour of a walk or mild housework.  Had none of this headache, tiredness, fatigue in the aftermath of COVID.  I feel debilitated in a way I have never experienced.
Pt developed itchy rash on right forearm approximately 6-8 hours after vaccine administration 9/10. Developed rash 9/11 with swollen oozing LL erythematous rash to face, neck, right arm. Penis/ Scrotum.
soreness; felt nodule; This case was reported by a nurse via sales rep and described the occurrence of pain in a 18-year-old female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero .5 ml. On an unknown date, unknown after receiving Bexsero, the patient experienced pain and injection site nodule. On an unknown date, the outcome of the pain was recovered/resolved and the outcome of the injection site nodule was not recovered/not resolved.   It was unknown if the reporter considered the pain and injection site nodule to be related to Bexsero.  Additional details were provided as follows: The age at vaccination was not reported. After an unknown period, the patient experienced initial soreness. The soreness went away, but the patient felt nodule. The nodule was still there after 2 weeks, but no more soreness was present. The reporter agreed to follow up from GSK. The description did not include that the nodule is at injection site, whereas injection site was retained as per the reported information in Argus core.
raise swelling at injection sight.; Swelling traveled from collarbone -shoulder - down arm into the hand; Jabbing pain/throbbing pain; tingling of hand; numbness of hand; Red at injection sight.; This is a spontaneous report from a non-contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 18Mar2021 at 11:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had unspecified allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medication within two weeks of vaccination. On 19Mar2021, the patient experienced red raise swelling at injection sight, swelling traveled from collarbone -shoulder - down arm into the hand, jabbing pain/throbbing pain, tingling and numbness. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the reported events which included chiropractic visits for nerve damage. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events red raise swelling at injection sight, swelling traveled from collarbone -shoulder - down arm into the hand, jabbing pain/throbbing pain, tingling and numbness was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
fever 104;febrile sz (24hrs p/vax); dx w/ear infect @ same time;
Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Hypotension-Mild, Systemic: Nausea-Mild, Systemic: Visual Changes/Disturbances-Mild, Additional Details: Patient received the vaccine. Within five minutes he asked to go to the bathroom to which he was advised to stay in the area. He did not look well so we asked if he was ok. He said he couldn't see well and he felt very tired and nauseous. He started coughing and saying he had trouble breathing. When I grabbed my emergency response kit he stated that he was breathing ok but just felt nauseous. We called 911 and his blood pressure was 80/60 mmhg. They did not give epipen. Brough to hospital.
Breakthrough case admission after 2 vaccines Pfizer 4/14/21 Lot# Ew0169;  Pfizer 5/5/21 Lot# EW0165
Golf ball swelling that was a bit tender over her deltoid. No redness or warmth that gradually decreased in size. 2 days after injection it was grape size with no redness or warmth. The injection hurt when given but second reaction in pt and so wanted to report it.
Abnormal bleeding started 2 days after vaccine . Last day of periods was only 8 days prior . Been spotting / light bleeding for 22 days straight and still hasn?t stopped. I have an appointment with the doc on 5/20
Diagnosed with a DVT of the left Axillary Vein. had received the Moderna vaccine in the same arm 10 days prior. Being evaluated for a PE at present.
Initial- Chest/heart pain, left shoulder pain 2 days after shot.  6/29 Pain additionally moved into left leg and left testicle and abdomen along with dull chest pain called primary care and referred to ER.  ER visit 6/29 and referred back to Primary care.  Saw Neurologist for prior scheduled post concussion appointment on 6/30 and expressed conditions and she thought it was possible Shingrex vaccination side effects and to see Primary care.  Also ordered Ultrasound for kidney and bladder as lab work from ER  showed low GFR levels (kidney issues).  Saw Primary care office 7/1 and perscibed Hyroxyzine and Famotidine.  Saw Dr 7/6 symptoms worsened. comtinued through 8/15.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE HYPOXEMIC RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXIA 1/17/2023 --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Extreme pain in left deltoid, large 2 inch red circle around injection site with swelling
Fever of at least 100.4 (Temp not taken until after taking several TYLENOL). Muscle ache and stiffness. Chills (Could not get warm). Tired. Hives (These developed at the injection site three days after injection).
Shots on 10/3/16- had quarter size red area on right leg for 4 days and then it went away. On 10/11/16- developed 2 inch long red area on other injection site on right leg- grandma said is hard, red and getting warmer. No fever and child acting ok.  Grandma called doctor office 10/13/16 and they prescribed Benadryl. Grandma called agency the same day and we called state nurse consultant for immunizations. She thought should go in to doctor to check it out. Called grandma back to inform.  Called grandma on Monday- 10/17/16 for follow up and stated ended up taking baby in on 10/13/16 to have it checked and was diagnosed with cellulitis. Is on antibiotics and the area is getting smaller as of 10/17/16.
Mother states 1 hour after receiving immunization child ran temp of 104, site gave Tylenol fever down to 102 (at 104 child was listless, not raising head, 102 child was grouchy). Child had diarrhea x2 days, fever 101 x1 week. Mother called pediatrician's office next day. No treatment, not seen in office.
This is a spontaneous report from a non-contactable consumer. A male consumer of unspecified age received TRUMENBA on unknown date, at single dose. Medical history and concomitant medications were not provided. After the consumer got the vaccine, he was having lot of muscle pain in his lower back and neck, kind of shooting muscle pain, it had been very achy, he was feeling not very good like he was getting sick. The events started in the morning on 24Sep2015 and towards the end of the day the consumer started getting worst slight headache. Events outcome was unknown. No follow up attempts possible. No further information expected.
At 12:28 PM during observation period after receiving her booster dose of Moderna COVID vaccine, the client walked up to the EMT station and reported she had a sensation of "closing of her throat" and feeling like a "cotton mouth." Client was calm, spoke in clear speech, stable on her feet, denied feeling shortness of breath, dizzy or pain. Co-lead nurse advised client to sit down on chair. Client drank some water and reported feeling less "tight" and swallowed a sips of water without any difficulty. Vital sign taken at 12:30 PM: Blood pressure was 138/90,  heart rate 92, respiration rate 18, and oxygen saturation at 98 percent.  Client reported she had a history COVID infection in December 2020, kidney donor (2011), seasonal allergy and not taking any medication. Client reported she had an allergic reaction to vitamin D shot in 2016 with "a swelling of lips and body." She reported she went to ER and was treated there with "Epi-shot." At 12:45 PM blood pressure was taken: 128/100, heart rate 87, respiration rate 18, and oxygen saturation at 98 percent. Co-lead nurse assessed client's throat and mouth and reported throat was soft to touch, denied tenderness to touch and no signs of swelling or inflammation with use of pen light. The client declined for staff to call 911 for further assessment. Co-lead nurse educated client on possible adverse effect, when to seek medical care and register on V-Safe. At 1:00 PM, the client left the facility with steady gait.
This spontaneous report as received from a consumer refers to her son, a male patient of unknown age. Information regarding relevant medical history and concurrent condition were not reported. "About a year ago", in approximately 2015, the patient completed the vaccination series for M-M-R II (dose, lot # and route not reported). On an unknown date, the patient received an extra dose of M-M-R II (lot # and route not reported) beyond what was recommended in the prescribing information (off label use and extra dose administered). No adverse experience reported. The outcome of the events was unknown. This is one of two reports refers to the same patient (related case ID: 1601USA007215). Additional information is not expected because there was no reporter's and health care professional's contact information provided.
the grandmother then developed chest pain/tightness; the grandmother then developed chest pain/tightness; She developed shortness of breath, redness, and "not feeling well" a few minutes after the PNEUMOV AX-23 shot.; She developed shortness of breath, redness, and "not feeling well" a few minutes after the PNEUMOV AX-23 shot.; She developed shortness of breath, redness, and "not feeling well" a few minutes after the PNEUMOV AX-23 shot.; This spontaneous report was received from a patient's grandchild and refers to a 75-year-old female patient. The patient's concurrent conditions included hypertension and diabetes mellitus. Her concomitant therapies included insulin, cyanocobalamin (Vitamin B 12), pregabalin (LYRICA), oxybutynin, metformin, simvastatin (manufacturer unknown), famotidine, Vitamin D, Vitamin A, quetiapine fumarate (SEROQUEL), lisinopril (manufacturer unknown) and hydrochlorothiazide (reported as HCTZ). She had no known drug allergies. On an unknown date, reported as "slightly before", the patient received a flu shot without incident.    On 04-SEP-2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection (lot #, expiry date, exact dose, route of administration and vaccination site were not specified) for prophylaxis.       On the same date, a few minutes after the vaccination, she developed shortness of breath, redness, and she was not feeling well. A member of the pharmacy staff where she received the vaccine gave her a shot of epinephrine. After this, the patient developed chest pain and tightness, and emergency medical services (EMS) was called. She was taken to the emergency room (sought medical attention), where a full exam was performed (including electrocardiogram (ECG) and "everything for the heart"). She received diphenhydramine hydrochloride (BENDARYL) and steroids in the hospital and she was there for almost a full day for observation after the vaccination. The outcome of the events was reported as recovering/resolving.     The aforementioned events were considered to be life threatening by the reporter.  Causality between the events and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not reported.